Chris Wolfe

CIK 1472624 · Chief Financial Officer · last filed 2026-03-03

Chris Wolfe is a Chief Financial Officer who has filed 6 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for SLQT, was dated Mar 3, 2026. Current disclosed insider exposure totals $4.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.9K

Companies

4

Total Filings

6

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

200 CLARENDON STREET
C/O BAIN CAPITAL INSURANCE SOLUTIONS, LP
BOSTON, MA 02116

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SLQT	Director	9,502	$0.51	$4.9K	$0	3	2026-03-03
DA32 Life Science Tech Acquisition Corp. (DALS) Delisted	Chief Financial Officer	—	$10.32	—	$0	1	2021-08-09
AdaptHealth Corp. (AHCOW) Delisted	Chief Financial Officer	60,000	—	—	$0	1	2019-11-13
CAREMARK ULYSSES HOLDING CORP. (UAM) Delisted	Director	2,800	—	—	$0	1	2010-06-04

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-03-03	SLQT	Exer (M)	+9,502	$0	EDGAR
2025-11-13	SLQT	Grant (A)	—	$0	EDGAR
2025-03-04	SLQT	Grant (A)	—	$0	EDGAR
2021-08-09	DA32 Life Science Tech Acquisition Corp. (DALS) Delisted	Disp (D)	—	$0	EDGAR
2019-11-13	AdaptHealth Corp. (AHCOW) Delisted	Other (J)	−40,000	$0	EDGAR
2010-06-04	CAREMARK ULYSSES HOLDING CORP. (UAM) Delisted	Grant (A)	+2,800	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.